healthBioNTech Accelerates Phase 2 Clinical Trials for BNT111 Personalized mRNA Cancer Vaccine Across European Hospitals
BioNTech has broadened clinical trial recruitment for its BNT111 cancer vaccine across leading European cancer centers, advancing mRNA immunotherapy for advanced melanoma patients.